<DOC>
	<DOCNO>NCT00204646</DOCNO>
	<brief_summary>Complete resection still curative treatment option patient soft tissue sarcoma ( STS ) . Patients non-resectable STS dismal prognosis even without evidence metastatic disease . The aim trial determine whether neoadjuvant dose-intensive chemo-radiotherapy feasible effective approach patient non-resectable STS .</brief_summary>
	<brief_title>Neoadjuvant Adriamycin Ifosfamide Plus High-Dose ICE Patients With Soft Tissue Sarcoma ( STS )</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>Histologically confirm STS locally advance nonresectable disease Metastatic disease allow case solitary resectable metastasis Grading accord Coindre &gt; IIÂ° Measurable tumor lesion Age &gt; 18 65 year Karnofsky status &gt; 70 % Written inform consent Prior chemotherapy Intercurrent disease interfere adequate administration study medication include severe psychological disease Insufficient liver , renal bone marrow function Evidence pregnancy Treatment within another clinical trial Uncontrolled viral Infections ( HIV , HBV , HCV ) malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>